This stock comparison examines KIDS and ZBH, two players in the orthopedic medical device sector. KIDS targets the niche pediatric market, while ZBH provides comprehensive solutions for broader orthopedic needs, including robotics. Investors seeking exposure to healthcare innovation, growth in specialized segments, or stable large-cap performers may find value in analyzing their relative performance, financial health, and market positioning. Amid evolving sector dynamics like aging populations and technological advancements, understanding these contrasts aids informed trading and portfolio decisions in the current market environment.
OrthoPediatrics Corp. (KIDS) designs, develops, and markets specialized implants, instruments, and braces for pediatric orthopedic conditions, serving surgeons and caregivers globally. With a market cap of approximately $416 million, the company focuses on trauma, deformity correction, and scoliosis products. In recent market activity, KIDS shares have traded in the mid-teens, near the lower end of their 52-week range ($14.91–$23.70), reflecting volatility amid broader small-cap pressures. YTD returns stand at +8.84%, supported by revenue of $236 million TTM but pressured by net losses of -$40 million and ROE (return on equity) of -11%. Sentiment has been buoyed by analyst upgrades, including a Zacks Rank #2 (Buy) in early March, with price targets suggesting upside potential ahead of upcoming earnings.
Zimmer Biomet Holdings, Inc. (ZBH) is a global medical technology leader offering orthopedic reconstructive products, sports medicine, and robotic systems like ROSA for knee arthroplasty. Headquartered in Warsaw, Indiana, like KIDS, it boasts a $17.7 billion market cap. Over recent weeks, shares have hovered around $91, down slightly within a 52-week range of $84.59–$108.29, influenced by pricing pressures and execution risks despite robotics growth and share buybacks. YTD performance is +1.77%, with trailing P/E of 25.71, forward P/E of 10.87, EPS of $3.55 TTM, and revenue of $8.23 billion supporting ROE of 5.60%. Upcoming Q1 earnings and analyst targets around $103 contribute to measured optimism.
Tickeron’s Trending AI Robots page features 25 top-performing AI trading bots selected from over 350 available, each employing machine learning for real-time signals across diverse strategies like trend trading, multi-ticker portfolios, and leveraged ETFs. These bots trade thousands of tickers with varying timeframes (5min to 60min) and styles, posting impressive stats: annualized returns from +15% to +167%, win rates of 48%–88%, profit factors up to 11.70, and profit-to-drawdown ratios to 21.53. Top examples include a semiconductor bot at +103% returns (64% win rate) and a leveraged tech bot at +127% (68% win rate). Curated for current market conditions, they offer risk-managed approaches with TP/SL (take-profit/stop-loss) corridors. Explore these high-conviction options to enhance your trading edge.
KIDS and ZBH both operate in orthopedic devices but differ markedly in scale and focus: KIDS’ niche pediatric emphasis drives growth potential in an underserved market, while ZBH leverages diversified revenue from hips/knees, sports medicine, and AI-enabled robotics for stability. Recent momentum favors KIDS YTD, but ZBH shows trend consistency with profitability versus KIDS’ losses. Risk factors include KIDS’ higher beta and debt/equity (32%), balanced by strong current ratio (5.55), against ZBH’s pricing headwinds and moderate leverage (62%). Sector exposure is pure medtech for both, with ZBH gaining from demographic tailwinds; market sentiment tilts toward ZBH’s scale amid volatility.
Tickeron’s AI tools, analyzing trend consistency, stability, and catalysts, currently lean toward ZBH over KIDS. ZBH benefits from proven profitability, attractive forward valuation, lower volatility, and robotics momentum positioning it favorably in a risk-averse environment, while KIDS offers niche upside tempered by losses and higher beta.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
KIDS’s FA Score shows that 1 FA rating(s) are green whileZBH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
KIDS’s TA Score shows that 5 TA indicator(s) are bullish while ZBH’s TA Score has 4 bullish TA indicator(s).
KIDS (@Medical/Nursing Services) experienced а +0.17% price change this week, while ZBH (@Medical/Nursing Services) price change was -1.33% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.40%. For the same industry, the average monthly price growth was -3.29%, and the average quarterly price growth was -15.87%.
KIDS is expected to report earnings on Aug 05, 2026.
ZBH is expected to report earnings on Aug 04, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| KIDS | ZBH | KIDS / ZBH | |
| Capitalization | 467M | 16.8B | 3% |
| EBITDA | -6.63M | 2.31B | -0% |
| Gain YTD | 2.365 | -2.884 | -82% |
| P/E Ratio | N/A | 22.56 | - |
| Revenue | 243M | 8.41B | 3% |
| Total Cash | 48.8M | 424M | 12% |
| Total Debt | 101M | 7.47B | 1% |
KIDS | ZBH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 63 | 69 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 95 | 83 | |
PRICE GROWTH RATING 1..100 | 50 | 55 | |
P/E GROWTH RATING 1..100 | 7 | 40 | |
SEASONALITY SCORE 1..100 | 65 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ZBH's Valuation (9) in the Medical Specialties industry is significantly better than the same rating for KIDS (91). This means that ZBH’s stock grew significantly faster than KIDS’s over the last 12 months.
ZBH's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as KIDS (100). This means that ZBH’s stock grew similarly to KIDS’s over the last 12 months.
ZBH's SMR Rating (83) in the Medical Specialties industry is in the same range as KIDS (95). This means that ZBH’s stock grew similarly to KIDS’s over the last 12 months.
KIDS's Price Growth Rating (50) in the Medical Specialties industry is in the same range as ZBH (55). This means that KIDS’s stock grew similarly to ZBH’s over the last 12 months.
KIDS's P/E Growth Rating (7) in the Medical Specialties industry is somewhat better than the same rating for ZBH (40). This means that KIDS’s stock grew somewhat faster than ZBH’s over the last 12 months.
| KIDS | ZBH | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 68% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 67% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 73% | N/A |
| TrendWeek ODDS (%) | 2 days ago 73% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 54% |
| Advances ODDS (%) | 8 days ago 73% | 19 days ago 64% |
| Declines ODDS (%) | 12 days ago 83% | 13 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 58% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 54% |
A.I.dvisor indicates that over the last year, KIDS has been loosely correlated with CNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KIDS jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To KIDS | 1D Price Change % | ||
|---|---|---|---|---|
| KIDS | 100% | -3.66% | ||
| CNMD - KIDS | 54% Loosely correlated | -0.12% | ||
| ENOV - KIDS | 48% Loosely correlated | -3.05% | ||
| XRAY - KIDS | 48% Loosely correlated | -1.74% | ||
| IART - KIDS | 46% Loosely correlated | +0.11% | ||
| ZBH - KIDS | 44% Loosely correlated | -1.00% | ||
More | ||||
A.I.dvisor indicates that over the last year, ZBH has been loosely correlated with KIDS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ZBH jumps, then KIDS could also see price increases.
| Ticker / NAME | Correlation To ZBH | 1D Price Change % | ||
|---|---|---|---|---|
| ZBH | 100% | -1.00% | ||
| KIDS - ZBH | 45% Loosely correlated | -3.66% | ||
| ENOV - ZBH | 45% Loosely correlated | -3.05% | ||
| CNMD - ZBH | 44% Loosely correlated | -0.12% | ||
| SYK - ZBH | 44% Loosely correlated | -1.01% | ||
| LIVN - ZBH | 44% Loosely correlated | +0.25% | ||
More | ||||